Telix Pharmaceuticals is a biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic ('theranostic') radiopharmaceuticals. The Finance Intern will support financial planning, budgeting, and reporting for R&D projects within Telix’s Therapeutics division, working closely with IT, finance, and project management to ensure effective cost management and strategic investment decisions.
Responsibilities
Assist with data validation, reconciliations, and variance analysis in Excel to support accurate budgeting and financial reporting for R&D projects.
Develop and optimize ETL processes for data extraction, transformation, and loading to support financial reporting.
Support data integration and automation efforts by developing scripts and processes (e.g., in Python, VBA, SQL) to streamline financial reporting, including ETL workflows and basic API-driven data exchanges.
Help maintain financial systems and tools for tracking expenditures and project costs against budgets and forecasts.
Support the preparation of financial reports, variance analyses, and compliance documentation.
Work with cross-functional teams to ensure data accuracy and integrity in financial reporting.
Qualification
Required
Currently pursuing a Bachelor's or Master’s degree in Finance, Accounting, or Information Systems
Automate workflows with strong analytical and problem-solving skills
Proficiency in Excel and financial modeling
Tech-savviness is essential to code and work with programming to develop scripts to optimize financial data processing
Excellent communication and teamwork abilities
Ability to manage multiple tasks in a fast-paced environment
Preferred
Familiarity with ERP systems is a plus
Interest in the biotech, pharmaceutical, or healthcare finance industry
Competitive salaries
Annual performance-based bonuses
An equity-based incentive program
Generous vacation
Paid wellness days
Support for learning and development
Telix is a biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic ('theranostic') radiopharmaceuticals.
